ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medications for Chronic Pain Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28B13131
Home | Market Reports | Health| Health Conditions| Pain Management
Global Medications for Chronic Pain Treatment Market Research Report 2023
BUY CHAPTERS

Global Medications for Chronic Pain Treatment Market Research Report 2025

Code: QYRE-Auto-28B13131
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Abbott Laboratories
Novartis
Johnson and Johnson Services Inc.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Bayer
Jiangsu Hengrui Medicine Co Ltd
REYOUNG
Southwest Pharmaceutical Co., Ltd.
Depomed
Endo International Plc.
Purdue Pharma L.P
Astrazeneca plc
Merck
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd

Medications for Chronic Pain Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Medications for Chronic Pain Treatment Market

Medications for Chronic Pain Treatment Market

The global market for Medications for Chronic Pain Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Medications for chronic pain treatment are pharmaceutical drugs prescribed by healthcare professionals to manage persistent and long-lasting pain conditions. Chronic pain is often defined as pain that persists for three months or longer and can result from various underlying causes, including injury, illness, or medical conditions. The goal of chronic pain medication is to alleviate pain, improve the patient"s quality of life, and enhance their ability to function.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Medications for Chronic Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medications for Chronic Pain Treatment.
The Medications for Chronic Pain Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medications for Chronic Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medications for Chronic Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Medications for Chronic Pain Treatment Market Report

Report Metric Details
Report Name Medications for Chronic Pain Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Abbott Laboratories, Novartis AG, Johnson and Johnson Services Inc., YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD., BAYER, Jiangsu Hengrui Medicine Co,.Ltd, REYOUNG, Southwest Pharmaceutical Co., Ltd., Depomed, Endo International plc., Purdue Pharma L.P., AstraZeneca plc., Merck & Co., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Medications for Chronic Pain Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Medications for Chronic Pain Treatment Market report?

Ans: The main players in the Medications for Chronic Pain Treatment Market are Pfizer, Abbott Laboratories, Novartis AG, Johnson and Johnson Services Inc., YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD., BAYER, Jiangsu Hengrui Medicine Co,.Ltd, REYOUNG, Southwest Pharmaceutical Co., Ltd., Depomed, Endo International plc., Purdue Pharma L.P., AstraZeneca plc., Merck & Co., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Medications for Chronic Pain Treatment Market report?

Ans: The Applications covered in the Medications for Chronic Pain Treatment Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Medications for Chronic Pain Treatment Market report?

Ans: The Types covered in the Medications for Chronic Pain Treatment Market report are Nonopioid, Opioids

Recommended Reports

Pain Therapeutics

Chronic Disease Drugs

Fibromyalgia & Neuropathy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nonopioid
1.2.3 Opioids
1.3 Market by Application
1.3.1 Global Medications for Chronic Pain Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medications for Chronic Pain Treatment Market Perspective (2020-2031)
2.2 Global Medications for Chronic Pain Treatment Growth Trends by Region
2.2.1 Global Medications for Chronic Pain Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Medications for Chronic Pain Treatment Historic Market Size by Region (2020-2025)
2.2.3 Medications for Chronic Pain Treatment Forecasted Market Size by Region (2026-2031)
2.3 Medications for Chronic Pain Treatment Market Dynamics
2.3.1 Medications for Chronic Pain Treatment Industry Trends
2.3.2 Medications for Chronic Pain Treatment Market Drivers
2.3.3 Medications for Chronic Pain Treatment Market Challenges
2.3.4 Medications for Chronic Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medications for Chronic Pain Treatment Players by Revenue
3.1.1 Global Top Medications for Chronic Pain Treatment Players by Revenue (2020-2025)
3.1.2 Global Medications for Chronic Pain Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Medications for Chronic Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Medications for Chronic Pain Treatment Revenue
3.4 Global Medications for Chronic Pain Treatment Market Concentration Ratio
3.4.1 Global Medications for Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medications for Chronic Pain Treatment Revenue in 2024
3.5 Global Key Players of Medications for Chronic Pain Treatment Head office and Area Served
3.6 Global Key Players of Medications for Chronic Pain Treatment, Product and Application
3.7 Global Key Players of Medications for Chronic Pain Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medications for Chronic Pain Treatment Breakdown Data by Type
4.1 Global Medications for Chronic Pain Treatment Historic Market Size by Type (2020-2025)
4.2 Global Medications for Chronic Pain Treatment Forecasted Market Size by Type (2026-2031)
5 Medications for Chronic Pain Treatment Breakdown Data by Application
5.1 Global Medications for Chronic Pain Treatment Historic Market Size by Application (2020-2025)
5.2 Global Medications for Chronic Pain Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Medications for Chronic Pain Treatment Market Size (2020-2031)
6.2 North America Medications for Chronic Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Medications for Chronic Pain Treatment Market Size by Country (2020-2025)
6.4 North America Medications for Chronic Pain Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medications for Chronic Pain Treatment Market Size (2020-2031)
7.2 Europe Medications for Chronic Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Medications for Chronic Pain Treatment Market Size by Country (2020-2025)
7.4 Europe Medications for Chronic Pain Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medications for Chronic Pain Treatment Market Size (2020-2031)
8.2 Asia-Pacific Medications for Chronic Pain Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Medications for Chronic Pain Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Medications for Chronic Pain Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medications for Chronic Pain Treatment Market Size (2020-2031)
9.2 Latin America Medications for Chronic Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Medications for Chronic Pain Treatment Market Size by Country (2020-2025)
9.4 Latin America Medications for Chronic Pain Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medications for Chronic Pain Treatment Market Size (2020-2031)
10.2 Middle East & Africa Medications for Chronic Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medications for Chronic Pain Treatment Introduction
11.1.4 Pfizer Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Medications for Chronic Pain Treatment Introduction
11.2.4 Abbott Laboratories Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Medications for Chronic Pain Treatment Introduction
11.3.4 Novartis AG Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.3.5 Novartis AG Recent Development
11.4 Johnson and Johnson Services Inc.
11.4.1 Johnson and Johnson Services Inc. Company Details
11.4.2 Johnson and Johnson Services Inc. Business Overview
11.4.3 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Introduction
11.4.4 Johnson and Johnson Services Inc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.4.5 Johnson and Johnson Services Inc. Recent Development
11.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
11.5.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Details
11.5.2 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
11.5.3 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Introduction
11.5.4 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.5.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Development
11.6 BAYER
11.6.1 BAYER Company Details
11.6.2 BAYER Business Overview
11.6.3 BAYER Medications for Chronic Pain Treatment Introduction
11.6.4 BAYER Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.6.5 BAYER Recent Development
11.7 Jiangsu Hengrui Medicine Co,.Ltd
11.7.1 Jiangsu Hengrui Medicine Co,.Ltd Company Details
11.7.2 Jiangsu Hengrui Medicine Co,.Ltd Business Overview
11.7.3 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Introduction
11.7.4 Jiangsu Hengrui Medicine Co,.Ltd Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.7.5 Jiangsu Hengrui Medicine Co,.Ltd Recent Development
11.8 REYOUNG
11.8.1 REYOUNG Company Details
11.8.2 REYOUNG Business Overview
11.8.3 REYOUNG Medications for Chronic Pain Treatment Introduction
11.8.4 REYOUNG Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.8.5 REYOUNG Recent Development
11.9 Southwest Pharmaceutical Co., Ltd.
11.9.1 Southwest Pharmaceutical Co., Ltd. Company Details
11.9.2 Southwest Pharmaceutical Co., Ltd. Business Overview
11.9.3 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Introduction
11.9.4 Southwest Pharmaceutical Co., Ltd. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.9.5 Southwest Pharmaceutical Co., Ltd. Recent Development
11.10 Depomed
11.10.1 Depomed Company Details
11.10.2 Depomed Business Overview
11.10.3 Depomed Medications for Chronic Pain Treatment Introduction
11.10.4 Depomed Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.10.5 Depomed Recent Development
11.11 Endo International plc.
11.11.1 Endo International plc. Company Details
11.11.2 Endo International plc. Business Overview
11.11.3 Endo International plc. Medications for Chronic Pain Treatment Introduction
11.11.4 Endo International plc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.11.5 Endo International plc. Recent Development
11.12 Purdue Pharma L.P.
11.12.1 Purdue Pharma L.P. Company Details
11.12.2 Purdue Pharma L.P. Business Overview
11.12.3 Purdue Pharma L.P. Medications for Chronic Pain Treatment Introduction
11.12.4 Purdue Pharma L.P. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.12.5 Purdue Pharma L.P. Recent Development
11.13 AstraZeneca plc.
11.13.1 AstraZeneca plc. Company Details
11.13.2 AstraZeneca plc. Business Overview
11.13.3 AstraZeneca plc. Medications for Chronic Pain Treatment Introduction
11.13.4 AstraZeneca plc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.13.5 AstraZeneca plc. Recent Development
11.14 Merck & Co.
11.14.1 Merck & Co. Company Details
11.14.2 Merck & Co. Business Overview
11.14.3 Merck & Co. Medications for Chronic Pain Treatment Introduction
11.14.4 Merck & Co. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.14.5 Merck & Co. Recent Development
11.15 GlaxoSmithKline plc.
11.15.1 GlaxoSmithKline plc. Company Details
11.15.2 GlaxoSmithKline plc. Business Overview
11.15.3 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Introduction
11.15.4 GlaxoSmithKline plc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.15.5 GlaxoSmithKline plc. Recent Development
11.16 Teva Pharmaceutical Industries Ltd.
11.16.1 Teva Pharmaceutical Industries Ltd. Company Details
11.16.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.16.3 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Introduction
11.16.4 Teva Pharmaceutical Industries Ltd. Revenue in Medications for Chronic Pain Treatment Business (2020-2025)
11.16.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Abbott Laboratories
Novartis
Johnson and Johnson Services Inc.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Bayer
Jiangsu Hengrui Medicine Co Ltd
REYOUNG
Southwest Pharmaceutical Co., Ltd.
Depomed
Endo International Plc.
Purdue Pharma L.P
Astrazeneca plc
Merck
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd
List of Tables
 Table 1. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Nonopioid
 Table 3. Key Players of Opioids
 Table 4. Global Medications for Chronic Pain Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Medications for Chronic Pain Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Medications for Chronic Pain Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Medications for Chronic Pain Treatment Market Share by Region (2020-2025)
 Table 8. Global Medications for Chronic Pain Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Medications for Chronic Pain Treatment Market Share by Region (2026-2031)
 Table 10. Medications for Chronic Pain Treatment Market Trends
 Table 11. Medications for Chronic Pain Treatment Market Drivers
 Table 12. Medications for Chronic Pain Treatment Market Challenges
 Table 13. Medications for Chronic Pain Treatment Market Restraints
 Table 14. Global Medications for Chronic Pain Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Medications for Chronic Pain Treatment Market Share by Players (2020-2025)
 Table 16. Global Top Medications for Chronic Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Chronic Pain Treatment as of 2024)
 Table 17. Ranking of Global Top Medications for Chronic Pain Treatment Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Medications for Chronic Pain Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Medications for Chronic Pain Treatment, Headquarters and Area Served
 Table 20. Global Key Players of Medications for Chronic Pain Treatment, Product and Application
 Table 21. Global Key Players of Medications for Chronic Pain Treatment, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Medications for Chronic Pain Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2020-2025)
 Table 25. Global Medications for Chronic Pain Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2026-2031)
 Table 27. Global Medications for Chronic Pain Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Medications for Chronic Pain Treatment Revenue Market Share by Application (2020-2025)
 Table 29. Global Medications for Chronic Pain Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Medications for Chronic Pain Treatment Revenue Market Share by Application (2026-2031)
 Table 31. North America Medications for Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Medications for Chronic Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Medications for Chronic Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Medications for Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Medications for Chronic Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Medications for Chronic Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Medications for Chronic Pain Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Medications for Chronic Pain Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Medications for Chronic Pain Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medications for Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Medications for Chronic Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Medications for Chronic Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Medications for Chronic Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Company Details
 Table 47. Pfizer Business Overview
 Table 48. Pfizer Medications for Chronic Pain Treatment Product
 Table 49. Pfizer Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Recent Development
 Table 51. Abbott Laboratories Company Details
 Table 52. Abbott Laboratories Business Overview
 Table 53. Abbott Laboratories Medications for Chronic Pain Treatment Product
 Table 54. Abbott Laboratories Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 55. Abbott Laboratories Recent Development
 Table 56. Novartis AG Company Details
 Table 57. Novartis AG Business Overview
 Table 58. Novartis AG Medications for Chronic Pain Treatment Product
 Table 59. Novartis AG Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 60. Novartis AG Recent Development
 Table 61. Johnson and Johnson Services Inc. Company Details
 Table 62. Johnson and Johnson Services Inc. Business Overview
 Table 63. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product
 Table 64. Johnson and Johnson Services Inc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 65. Johnson and Johnson Services Inc. Recent Development
 Table 66. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Details
 Table 67. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
 Table 68. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product
 Table 69. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 70. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Development
 Table 71. BAYER Company Details
 Table 72. BAYER Business Overview
 Table 73. BAYER Medications for Chronic Pain Treatment Product
 Table 74. BAYER Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 75. BAYER Recent Development
 Table 76. Jiangsu Hengrui Medicine Co,.Ltd Company Details
 Table 77. Jiangsu Hengrui Medicine Co,.Ltd Business Overview
 Table 78. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product
 Table 79. Jiangsu Hengrui Medicine Co,.Ltd Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 80. Jiangsu Hengrui Medicine Co,.Ltd Recent Development
 Table 81. REYOUNG Company Details
 Table 82. REYOUNG Business Overview
 Table 83. REYOUNG Medications for Chronic Pain Treatment Product
 Table 84. REYOUNG Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 85. REYOUNG Recent Development
 Table 86. Southwest Pharmaceutical Co., Ltd. Company Details
 Table 87. Southwest Pharmaceutical Co., Ltd. Business Overview
 Table 88. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product
 Table 89. Southwest Pharmaceutical Co., Ltd. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 90. Southwest Pharmaceutical Co., Ltd. Recent Development
 Table 91. Depomed Company Details
 Table 92. Depomed Business Overview
 Table 93. Depomed Medications for Chronic Pain Treatment Product
 Table 94. Depomed Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 95. Depomed Recent Development
 Table 96. Endo International plc. Company Details
 Table 97. Endo International plc. Business Overview
 Table 98. Endo International plc. Medications for Chronic Pain Treatment Product
 Table 99. Endo International plc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 100. Endo International plc. Recent Development
 Table 101. Purdue Pharma L.P. Company Details
 Table 102. Purdue Pharma L.P. Business Overview
 Table 103. Purdue Pharma L.P. Medications for Chronic Pain Treatment Product
 Table 104. Purdue Pharma L.P. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 105. Purdue Pharma L.P. Recent Development
 Table 106. AstraZeneca plc. Company Details
 Table 107. AstraZeneca plc. Business Overview
 Table 108. AstraZeneca plc. Medications for Chronic Pain Treatment Product
 Table 109. AstraZeneca plc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 110. AstraZeneca plc. Recent Development
 Table 111. Merck & Co. Company Details
 Table 112. Merck & Co. Business Overview
 Table 113. Merck & Co. Medications for Chronic Pain Treatment Product
 Table 114. Merck & Co. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 115. Merck & Co. Recent Development
 Table 116. GlaxoSmithKline plc. Company Details
 Table 117. GlaxoSmithKline plc. Business Overview
 Table 118. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product
 Table 119. GlaxoSmithKline plc. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 120. GlaxoSmithKline plc. Recent Development
 Table 121. Teva Pharmaceutical Industries Ltd. Company Details
 Table 122. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 123. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product
 Table 124. Teva Pharmaceutical Industries Ltd. Revenue in Medications for Chronic Pain Treatment Business (2020-2025) & (US$ Million)
 Table 125. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Medications for Chronic Pain Treatment Picture
 Figure 2. Global Medications for Chronic Pain Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medications for Chronic Pain Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Nonopioid Features
 Figure 5. Opioids Features
 Figure 6. Global Medications for Chronic Pain Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Medications for Chronic Pain Treatment Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. Medications for Chronic Pain Treatment Report Years Considered
 Figure 12. Global Medications for Chronic Pain Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Medications for Chronic Pain Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Medications for Chronic Pain Treatment Market Share by Region: 2024 VS 2031
 Figure 15. Global Medications for Chronic Pain Treatment Market Share by Players in 2024
 Figure 16. Global Top Medications for Chronic Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Chronic Pain Treatment as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Medications for Chronic Pain Treatment Revenue in 2024
 Figure 18. North America Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Medications for Chronic Pain Treatment Market Share by Country (2020-2031)
 Figure 20. United States Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Medications for Chronic Pain Treatment Market Share by Country (2020-2031)
 Figure 24. Germany Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Medications for Chronic Pain Treatment Market Share by Region (2020-2031)
 Figure 32. China Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Medications for Chronic Pain Treatment Market Share by Country (2020-2031)
 Figure 40. Mexico Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Medications for Chronic Pain Treatment Market Share by Country (2020-2031)
 Figure 44. Turkey Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Medications for Chronic Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Pfizer Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 48. Abbott Laboratories Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 49. Novartis AG Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 50. Johnson and Johnson Services Inc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 51. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 52. BAYER Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 53. Jiangsu Hengrui Medicine Co,.Ltd Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 54. REYOUNG Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 55. Southwest Pharmaceutical Co., Ltd. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 56. Depomed Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 57. Endo International plc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 58. Purdue Pharma L.P. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 59. AstraZeneca plc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 60. Merck & Co. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 61. GlaxoSmithKline plc. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 62. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Medications for Chronic Pain Treatment Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Pain Treatment Market Insights Forecast to 2030
Global Chronic Pain Management Drugs Market Research Report 2025
Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Pelvic Pain Treatment Market Research Report 2025
Global Pain Management Drugs Devices Market Research Report 2025
Chronic Low Back Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bone Pain Treatment Market
Global Chronic Disease Treatment Market Research Report 2024
Veterinary Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Spine Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Treatment Medication Market Research Report 2025
Pain Management Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Migraine Treatment Market Research Report 2024
Spine Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Conventional and Alternative Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Pain Management Market Insights Forecast to 2030
Hip Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Constipation Treatment Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions